HIV and AIDS Trial, Recruiting (NCT06103370)

HIV and AIDS Trial, Recruiting NCT06103370 Sponsor: Johns Hopkins University Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06103370 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For "Index" participants (people who take on a peer educator role):

People aged 18 or older
People who report having injected drugs in the past month
People who have used services at the needle/syringe program (SSP) in the past 3 months
People who are willing to attend training and weekly group sessions
People who are able to bring at least 1 fellow drug-using contact into the study
People who are willing to talk with peers about topics like HIV prevention and care
People who have not previously taken part in this study in any role
People who speak English

For "Network Member" participants (people brought in by an index participant):

People aged 18 or older
People who report having injected drugs in the past month
People who have a valid referral coupon, or who can recall the 3-digit ID number associated with it
People who have not previously taken part in this study in any role
People who speak English

Who may not be able to join:

People who do not have the mental capacity to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Oluwaseun Falade-Nwulia, MBBS, MPH, Johns Hopkins School of Medicine

Phone: 410-550-6234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06103370

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 410-550-6234

More information: https://clinicaltrials.gov/study/NCT06103370

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For "Index" participants (people who take on a peer educator role):

People aged 18 or older
People who report having injected drugs in the past month
People who have used services at the needle/syringe program (SSP) in the past 3 months
People who are willing to attend training and weekly group sessions
People who are able to bring at least 1 fellow drug-using contact into the study
People who are willing to talk with peers about topics like HIV prevention and care
People who have not previously taken part in this study in any role
People who speak English

For "Network Member" participants (people brought in by an index participant):

People aged 18 or older
People who report having injected drugs in the past month
People who have a valid referral coupon, or who can recall the 3-digit ID number associated with it
People who have not previously taken part in this study in any role
People who speak English

Who may not be able to join:

People who do not have the mental capacity to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

28 October 2025

Est. completion

1 November 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of HIV testing for Network Members

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov